 
                        | Product NDC: | 65862-558 | 
| Proprietary Name: | Minocycline Hydrochloride | 
| Non Proprietary Name: | Minocycline Hydrochloride | 
| Active Ingredient(s): | 135 mg/1 & nbsp; Minocycline Hydrochloride | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 65862-558 | 
| Labeler Name: | Aurobindo Pharma Limited | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA202261 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20121119 | 
| Package NDC: | 65862-558-99 | 
| Package Description: | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-558-99) | 
| NDC Code | 65862-558-99 | 
| Proprietary Name | Minocycline Hydrochloride | 
| Package Description | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-558-99) | 
| Product NDC | 65862-558 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Minocycline Hydrochloride | 
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20121119 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Aurobindo Pharma Limited | 
| Substance Name | MINOCYCLINE HYDROCHLORIDE | 
| Strength Number | 135 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient] |